🔎 Trials Near Me

Pradžia › Pjautinio ląstelės anemija › Ilinoisas › Chicago

Pjautinio ląstelės anemija klinikiniai tyrimai Chicago, IL

18 tyrimai dėl Pjautinio ląstelės anemija ieško dalyvių vietose Chicago ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease

Renkami dalyviai1 fazė
  • University of Illinois at Chicago College of Medicine, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT04055818

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Renkami dalyviai3 fazė
  • Uni of Illinois Hospital and HSC, Chicago
Amžius nuo 12 iki 100 · Visoms lytims · Atnaujinta 2026-09-28 · NCT06439082

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

Renkami dalyviai1 fazė
  • University of Illinois Hospital and Health Sciences System, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT07187973

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

Renkami dalyviai3 fazė
  • Univer Of Illinois at Chicago, Chicago
Amžius 2 ir vyresni · Visoms lytims · Atnaujinta 2026-09-18 · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

Renkami dalyviai3 fazė
  • Childrens Hospital of Chicago, Chicago
  • Univer Of Illinois at Chicago, Chicago
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT06612268

Tocilizumab for Acute Chest Syndrome

Renkami dalyviai2 fazė
  • University of Chicago, Chicago
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-15 · NCT05640271

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai
  • Local Institution - 0034, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-18 · NCT06481306

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

Renkami dalyviai2/3 fazė
  • University of Illinois at Chicago Clinical Research Center, Chicago
  • University of Illinois Hospital and Health Sciences System - Investigational Drug Services (IDS), Chicago
  • University of Illinois Hospital and Health Sciences System, Chicago
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-08-18 · NCT05431088

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Renkami dalyviaiStebimasis tyrimas
  • Rush University Medical Center, Chicago
Visi amžiai · Visoms lytims · Atnaujinta 2026-08-17 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

Renkami dalyviai2 fazė
  • University of Illinois at Chicago, Chicago
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-08-14 · NCT06699849

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

Renkami dalyviai3 fazė
  • University of Illinois-Chicago - College of Medicine- Site Number : 8400054, Chicago
Amžius nuo 10 iki 65 · Visoms lytims · Atnaujinta 2026-07-29 · NCT06975865

Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease

Renkami dalyviai2 fazė
  • University of Illinois at Chicago, Chicago
Amžius nuo 16 iki 60 · Visoms lytims · Atnaujinta 2026-07-08 · NCT03121001

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

Renkami dalyviaiStebimasis tyrimas
  • Comer Children's Hospital (MRD-HCT), Chicago
Amžius nuo 3 iki 20 · Visoms lytims · Atnaujinta 2026-06-04 · NCT06941389

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

Renkami dalyviai2 fazė
  • University of Illinois Chicago, Sickle Cell Center, Chicago
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-05-19 · NCT07175051

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

Renkami dalyviai
  • University of Illinois at Chicago, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-23 · NCT06919224

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

Renkami dalyviai2 fazė
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Amžius nuo 2 iki 25 · Visoms lytims · Atnaujinta 2026-03-10 · NCT03587272

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

Renkami dalyviai
  • Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
Amžius nuo 16 iki 30 · Visoms lytims · Atnaujinta 2026-01-07 · NCT06374238

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

Renkami dalyviaiStebimasis tyrimas
  • University of Illinois, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-06-22 · NCT06385886

Pjautinio ląstelės anemija tyrimai kituose miestuose

Kiti tyrimai Chicago

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.